The Project Management Institute Announces Winners of 2020 PMI® Awards
16.11.2020 17:45:00 EET | Business Wire | Press release
On Tuesday, 20 October, Project Management Institute (PMI) announced the winners of the 2020 PMI® Professional Awards during the Virtual Experience Series event, A New World View: Our Global Impact.
Since 1974, the prestigious PMI Professional Awards have honored organizations and individuals whose passion, talent, and expertise have made the greatest contributions to the project management profession or to PMI.
This year’s PMI Research and Academic Award winners have also been selected. These awards recognize those who have made sustained or significant contributions through teaching, research, or literature.
For more information on the award programs: https://www.pmi.org/about/awards.
PMI® Professional Awards:
PMI Project of the Year – This award recognizes the large and complex project that best delivers superior performance of project management practices, superior organizational results, and positive impacts on society with a project budget of more than US$100 million.
- Winner: The Trans Anatolian Natural Gas Pipeline (TANAP) Project, TANAP Natural Gas Transmission Company (Ankara, Turkey)
- Finalist: Revitalisation de la Tour de Montréal – Montréal Tower Revitalization Project, Parc Olympique (Montréal, Québec, Canada)
- Finalist: Fort McMurray West 500 kV Transmission Project, ATCO (Edmonton, Alberta, Canada)
PMO OF THE YEAR® Award– This award honors a Project Management Office (PMO) that has added value to its organization through its support of successful strategic initiatives and demonstrated superior organizational project management capabilities. It also recognizes a PMO that has established a vision for value delivery and has had a positive and clear impact on business results.
- Winner: DC Water – IT Project Management Office : IT Project Management Office – Making I.T. Happen, (Washington, D.C., U.S.)
- Finalist: Emaar Properties PJSC – Group Operations: Emaar Properties - Group Operations: Strategic Project Management Office(Dubai, United Arab Emirates)
- Finalist: Kern Health Systems: Kern Health Systems Enterprise Project Management Office(Bakersfield, California, U.S.)
PMI Project Excellence Award – This award recognizes complex projects that best deliver superior performance of project management practices, superior organizational results, and positive impacts on society with a project budget of less than US$100 million.
- Asia Pacific Region: PROJECT RURAL MPOWERMENT, Mobitel (Pvt) Ltd (Colombo, Sri Lanka)
- Europe, Middle East, Africa Region: Shaybah Airport Runway Upgrade Project, Saudi Aramco – Oil Facilities Projects Department (Dhahran, Saudi Arabia)
- North America Region: Data-Center Co-Location Project, Adventist Health/ Highmark Solutions (Roseville, California, USA)
PMI Fellow Award – This is the highest and most prestigious individual award presented by Project Management Institute for service to the organization and profession.
- Marge Combe, PMI Fellow
- Dr. Prasad S. Kodukula, PMP, PgMP, PMI Fellow
PMI Eric Jenett Project Management Excellence Award – This award recognizes and honors an individual who has made an outstanding contribution(s) to the project management profession or its practice through leadership, technical project management, and strategic and business management acumen.
- Vanita Ahuja, PhD, PgMP, MRICS
- Dr. Krishna Kumar T I PhD, CDAI
- Kenneth Bainey MBA, PMP
PMI Young Professional Award – This award recognizes and honors young professionals who have made a significant impact in advancing project management within an organization, advancing the knowledge and understanding of the practice of project management, and demonstrating an understanding of PMI standards, practices and ethics.
- Nguyen Si Trieu Chau, LIMC, PfMP, PgMP, PMP, PMI-ACP, PMI-RMP, PMI-SP, IPMO-E, PMO-CP
- Lt. Dimitrios Zaires Exec. MSc, MBA, CMILT, PMI-RMP
- Roman Reznikov
- Dr. Ritu Ahuja, PMI-ACP, MRICS
PMI® Research and Academic Award Winners:
PMI Research Achievement Award – This award recognizes and honors an individual or group of individuals whose work has significantly advanced the concepts, knowledge, and practices of project management through a published body of academic research.
- Professor Monique Aubry, PhD, MPM
PMI Linn Stuckenbruck Teaching Excellence Award – This award recognizes and honors an individual faculty member for excellence in teaching project management, and for their strong commitment to improving and enhancing project management curricula in higher education.
- Callum Robert Kidd (University of Manchester)
PMI Project Management Journal® Paper of the Year Award – This award recognizes the best paper published in the Project Management Journal in the previous year.
- “How Digital Information Transforms Project Delivery Models” by Professor Jennifer Whyte
PMI David I. Cleland Project Management Literature Award – This award recognizes the author(s) of a published book that significantly advances project management knowledge, concepts, and practice.
- “Project Management: A Benefit Realisation Approach” by Professor Ofer Zwikael and John R Smyrk
Find the list of PMI award winners: https://www.pmi.org/about/awards/winners
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® interactive website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com, www.facebook.com/PMInstitute and on Twitter @PMInstitute
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005763/en/
Contact information
Media:
Drew Pradeep
Tel: 610-416-6023
Drew.Pradeep@pmi.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
